These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 19838161)

  • 21. Translocation of BCL2 and BCL6 to the same immunoglobulin heavy chain locus in a case of follicular lymphoma.
    Rack K; Delannoy A; Ravoet C; Vannuffel P; Hamels J; Gillerot Y
    Leuk Lymphoma; 2005 Oct; 46(10):1513-6. PubMed ID: 16194898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphoid follicle colonization by Bcl-2(bright+)CD10(+) B-cells ("follicular lymphoma in situ") at nodal and extranodal sites can be a manifestation of follicular homing of lymphoma.
    Lee JC; Hoehn D; Schecter J; Murty VV; Mansukhani MM; Alobeid B; Bhagat G
    Hum Pathol; 2013 Jul; 44(7):1328-40. PubMed ID: 23363648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles.
    Horn H; Schmelter C; Leich E; Salaverria I; Katzenberger T; Ott MM; Kalla J; Romero M; Siebert R; Rosenwald A; Ott G
    Haematologica; 2011 Sep; 96(9):1327-34. PubMed ID: 21659362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component.
    Katzenberger T; Ott G; Klein T; Kalla J; Müller-Hermelink HK; Ott MM
    Am J Pathol; 2004 Aug; 165(2):481-90. PubMed ID: 15277222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological analysis of follicular lymphoma with BCL2, BCL6, and MYC rearrangements.
    Ikoma H; Miyaoka M; Hiraiwa S; Yukie Kikuti Y; Shiraiwa S; Hara R; Kojima M; Ohmachi K; Ando K; Carreras J; Nakamura N
    Pathol Int; 2022 Jun; 72(6):321-331. PubMed ID: 35297566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical relevance of BCL2, BCL6, and MYC rearrangements in diffuse large B-cell lymphoma.
    Kramer MH; Hermans J; Wijburg E; Philippo K; Geelen E; van Krieken JH; de Jong D; Maartense E; Schuuring E; Kluin PM
    Blood; 1998 Nov; 92(9):3152-62. PubMed ID: 9787151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups.
    Marafioti T; Copie-Bergman C; Calaminici M; Paterson JC; Shende VH; Liu H; Baia M; Ramsay AD; Agostinelli C; Brière J; Clear A; Du MQ; Piccaluga PP; Masir N; Nacheva EP; Sujobert P; Shanmugam K; Grogan TM; Brooks SP; Khwaja A; Ardeshna K; Townsend W; Pileri SA; Haioun C; Linch D; Gribben JG; Gaulard P; Isaacson PG
    Histopathology; 2013 May; 62(6):860-75. PubMed ID: 23509938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral follicular lymphomas. A short report of 8 cases with assessment of the IGH/BCL2 gene fusion with fluorescence in situ hybridization.
    Argyris PP; Dolan M; Piperi E; Tosios KI; Pambuccian SE; Koutlas IG
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Sep; 116(3):343-7. PubMed ID: 23953419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes.
    Horsman DE; Okamoto I; Ludkovski O; Le N; Harder L; Gesk S; Siebert R; Chhanabhai M; Sehn L; Connors JM; Gascoyne RD
    Br J Haematol; 2003 Feb; 120(3):424-33. PubMed ID: 12580956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Translocation t(14;18)/IGH-BCL2 in gastrointestinal follicular lymphoma: correlation with clinicopathologic features in 48 patients.
    Yanai S; Nakamura S; Takeshita M; Fujita K; Hirahashi M; Kawasaki K; Kurahara K; Sakai Y; Matsumoto T
    Cancer; 2011 Jun; 117(11):2467-77. PubMed ID: 24048795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?
    Palmedo G; Hantschke M; Rütten A; Mentzel T; Kempf W; Tomasini D; Kutzner H
    Am J Dermatopathol; 2007 Jun; 29(3):231-6. PubMed ID: 17519619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Primary ocular adnexal lymphoproliferative lesions: clinicopathologic features and genetic alterations].
    Dong LN; Liu HG; Jin HS; Ye HT; Gao ZF; Zhou XG; Dong GH; Zhang DD; Gong LP
    Zhonghua Bing Li Xue Za Zhi; 2008 Dec; 37(12):809-14. PubMed ID: 19159526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.
    Li S; Lin P; Fayad LE; Lennon PA; Miranda RN; Yin CC; Lin E; Medeiros LJ
    Mod Pathol; 2012 Jan; 25(1):145-56. PubMed ID: 22002575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follicular lymphoma of the spleen: multiparameter analysis of 16 cases.
    Howard MT; Dufresne S; Swerdlow SH; Cook JR
    Am J Clin Pathol; 2009 May; 131(5):656-62. PubMed ID: 19369624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BCL2, BCL6, MYC, MALT 1, and BCL10 rearrangements in nodal diffuse large B-cell lymphomas: a multicenter evaluation of a new set of fluorescent in situ hybridization probes and correlation with clinical outcome.
    Tibiletti MG; Martin V; Bernasconi B; Del Curto B; Pecciarini L; Uccella S; Pruneri G; Ponzoni M; Mazzucchelli L; Martinelli G; Ferreri AJ; Pinotti G; Assanelli A; Scandurra M; Doglioni C; Zucca E; Capella C; Bertoni F
    Hum Pathol; 2009 May; 40(5):645-52. PubMed ID: 19144384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunophenotypic and cytogenetic findings of B-lymphoblastic leukemia/lymphoma associated with combined IGH/BCL2 and MYC rearrangement.
    Kelemen K; Holden J; Johnson LJ; Davion S; Robetorye RS
    Cytometry B Clin Cytom; 2017 Jul; 92(4):310-314. PubMed ID: 26517296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The spectrum of B-cell non-Hodgkin lymphomas with dual IgH-BCL2 and BCL6 translocations.
    Keller CE; Nandula S; Fisher J; Subramaniyam S; Vakiani E; Savage DG; Murty VV; Alobeid B; Bhagat G
    Am J Clin Pathol; 2008 Aug; 130(2):193-201. PubMed ID: 18628087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathologic and genetic characterization of follicular lymphomas presenting in the ovary reveals 2 distinct subgroups.
    Ozsan N; Bedke BJ; Law ME; Inwards DJ; Ketterling RP; Knudson RA; Keeney GL; Dogan A; Feldman AL
    Am J Surg Pathol; 2011 Nov; 35(11):1691-9. PubMed ID: 21997689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma.
    Belaud-Rotureau MA; Parrens M; Carrere N; Turmo M; Ferrer J; de Mascarel A; Dubus P; Merlio JP
    Hum Pathol; 2007 Feb; 38(2):365-72. PubMed ID: 17134735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorescence immunophenotypic and interphase cytogenetic characterization of nodal lymphoplasmacytic lymphoma.
    Sargent RL; Cook JR; Aguilera NI; Surti U; Abbondanzo SL; Gollin SM; Swerdlow SH
    Am J Surg Pathol; 2008 Nov; 32(11):1643-53. PubMed ID: 18670352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.